415 related articles for article (PubMed ID: 25505143)
21. DNA targeting by the type I-G and type I-A CRISPR-Cas systems of Pyrococcus furiosus.
Elmore J; Deighan T; Westpheling J; Terns RM; Terns MP
Nucleic Acids Res; 2015 Dec; 43(21):10353-63. PubMed ID: 26519471
[TBL] [Abstract][Full Text] [Related]
22. Modulation of CRISPR locus transcription by the repeat-binding protein Cbp1 in Sulfolobus.
Deng L; Kenchappa CS; Peng X; She Q; Garrett RA
Nucleic Acids Res; 2012 Mar; 40(6):2470-80. PubMed ID: 22139923
[TBL] [Abstract][Full Text] [Related]
23. Inactivation of Target RNA Cleavage of a III-B CRISPR-Cas System Induces Robust Autoimmunity in
Zhang Y; Lin J; Tian X; Wang Y; Zhao R; Wu C; Wang X; Zhao P; Bi X; Yu Z; Han W; Peng N; Liang YX; She Q
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955649
[TBL] [Abstract][Full Text] [Related]
24. Gene Repression in Haloarchaea Using the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas I-B System.
Stachler AE; Marchfelder A
J Biol Chem; 2016 Jul; 291(29):15226-42. PubMed ID: 27226589
[TBL] [Abstract][Full Text] [Related]
25. Crystallization and preliminary X-ray diffraction analysis of the CRISPR-Cas RNA-silencing Cmr complex.
Osawa T; Inanaga H; Numata T
Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):735-40. PubMed ID: 26057804
[TBL] [Abstract][Full Text] [Related]
26. Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs.
Hale CR; Majumdar S; Elmore J; Pfister N; Compton M; Olson S; Resch AM; Glover CV; Graveley BR; Terns RM; Terns MP
Mol Cell; 2012 Feb; 45(3):292-302. PubMed ID: 22227116
[TBL] [Abstract][Full Text] [Related]
27. Cas4 Nucleases Can Effect Specific Integration of CRISPR Spacers.
Zhang Z; Pan S; Liu T; Li Y; Peng N
J Bacteriol; 2019 Jun; 201(12):. PubMed ID: 30936372
[TBL] [Abstract][Full Text] [Related]
28. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex.
Hale CR; Zhao P; Olson S; Duff MO; Graveley BR; Wells L; Terns RM; Terns MP
Cell; 2009 Nov; 139(5):945-56. PubMed ID: 19945378
[TBL] [Abstract][Full Text] [Related]
29. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family.
Hrle A; Maier LK; Sharma K; Ebert J; Basquin C; Urlaub H; Marchfelder A; Conti E
RNA Biol; 2014; 11(8):1072-82. PubMed ID: 25483036
[TBL] [Abstract][Full Text] [Related]
30. CRISPR-Associated Factor Csa3b Regulates CRISPR Adaptation and Cmr-Mediated RNA Interference in
Ye Q; Zhao X; Liu J; Zeng Z; Zhang Z; Liu T; Li Y; Han W; Peng N
Front Microbiol; 2020; 11():2038. PubMed ID: 32983033
[TBL] [Abstract][Full Text] [Related]
31. Two CRISPR-Cas systems in Methanosarcina mazei strain Gö1 display common processing features despite belonging to different types I and III.
Nickel L; Weidenbach K; Jäger D; Backofen R; Lange SJ; Heidrich N; Schmitz RA
RNA Biol; 2013 May; 10(5):779-91. PubMed ID: 23619576
[TBL] [Abstract][Full Text] [Related]
32. Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex.
Hale CR; Cocozaki A; Li H; Terns RM; Terns MP
Genes Dev; 2014 Nov; 28(21):2432-43. PubMed ID: 25367038
[TBL] [Abstract][Full Text] [Related]
33. Structural biology. Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning.
Taylor DW; Zhu Y; Staals RH; Kornfeld JE; Shinkai A; van der Oost J; Nogales E; Doudna JA
Science; 2015 May; 348(6234):581-5. PubMed ID: 25837515
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of ribonucleoprotein effector complexes of Sulfolobus islandicus CRISPR-Cas systems.
Feng M; She Q
Methods Enzymol; 2021; 659():327-347. PubMed ID: 34752293
[TBL] [Abstract][Full Text] [Related]
35. Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system.
Elmore JR; Sheppard NF; Ramia N; Deighan T; Li H; Terns RM; Terns MP
Genes Dev; 2016 Feb; 30(4):447-59. PubMed ID: 26848045
[TBL] [Abstract][Full Text] [Related]
36. Efficient CRISPR-Mediated Post-Transcriptional Gene Silencing in a Hyperthermophilic Archaeon Using Multiplexed crRNA Expression.
Zebec Z; Zink IA; Kerou M; Schleper C
G3 (Bethesda); 2016 Oct; 6(10):3161-3168. PubMed ID: 27507792
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis for inhibition of type III-B CRISPR-Cas by an archaeal viral anti-CRISPR protein.
Lin J; Alfastsen L; Bhoobalan-Chitty Y; Peng X
Cell Host Microbe; 2023 Nov; 31(11):1837-1849.e5. PubMed ID: 37909049
[TBL] [Abstract][Full Text] [Related]
38. DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes.
Plagens A; Richter H; Charpentier E; Randau L
FEMS Microbiol Rev; 2015 May; 39(3):442-63. PubMed ID: 25934119
[TBL] [Abstract][Full Text] [Related]
39. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity.
Charpentier E; Richter H; van der Oost J; White MF
FEMS Microbiol Rev; 2015 May; 39(3):428-41. PubMed ID: 25994611
[TBL] [Abstract][Full Text] [Related]
40. Structure of the archaeal Cascade subunit Csa5: relating the small subunits of CRISPR effector complexes.
Reeks J; Graham S; Anderson L; Liu H; White MF; Naismith JH
RNA Biol; 2013 May; 10(5):762-9. PubMed ID: 23846216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
